This is a general term for any type of tumor or cancer that starts in the adrenal glands. These glands sit on top of your kidneys and produce hormones that help control your blood pressure, blood sugar, and other functions. Cancer in these glands is sometimes called adrenal cancer.
Every report comes from a Lived member, sent anonymously.
Have you had Adrenalectomy for Adrenal Gland Cancer?
Adrenal gland cancer is cancer that starts in one of the two adrenal glands, small glands that sit on top of the kidneys. These glands make hormones the body cannot live without, including cortisol (which helps control blood sugar, blood pressure and the response to stress), aldosterone (which balances salt, water and blood pressure), adrenaline and some sex hormones. Because of that, a tumor here can cause trouble in two ways: by growing and pressing on nearby organs, or by making too much of a hormone. Most growths in an adrenal gland are not cancer. Benign tumors called adenomas are common and are often found by chance on a scan done for another reason. Adrenal cancer itself is rare. The main type in adults is adrenocortical carcinoma, which starts in the outer layer of the gland (the cortex); about 300 to 400 cases are diagnosed in the United States each year. Tumors of the inner part (the medulla) include pheochromocytoma, which is usually benign but is cancerous in about 1 in 10 cases, and neuroblastoma, a cancer of young children. Cancer that began somewhere else in the body can also spread to an adrenal gland. Symptoms depend on what the tumor does. One that makes excess cortisol can cause weight gain in the face, neck and trunk with thin arms and legs, a round red face, muscle weakness, high blood sugar and high blood pressure. Excess aldosterone causes high blood pressure, muscle weakness or cramps, thirst and frequent urination. Excess male hormones can cause facial hair, acne, a deeper voice and missed periods in women, while excess estrogen can cause breast growth and lower sex drive in men. A pheochromocytoma can cause episodes of headache, sweating and a pounding heart. A tumor that makes no extra hormones may cause nothing noticeable until it is large enough to cause a lump, a feeling of fullness, or pain in the abdomen or back.
For most people with adrenocortical carcinoma, no cause can be identified. The cancer grows from changes in genes that control how cells grow and divide, and most of these changes happen by chance during life rather than being inherited. It is somewhat more common in women and tends to appear at two points in life: in children under 5 and in adults in their 40s and 50s. Some inherited conditions raise the risk. Li-Fraumeni syndrome, caused by a change in a gene called TP53, accounts for more than half of adrenocortical carcinomas in children and about 1 in 20 in adults. Beckwith-Wiedemann syndrome, Lynch syndrome, multiple endocrine neoplasia type 1 (MEN1) and familial adenomatous polyposis are also linked to adrenal tumors, although many of these tumors are benign. Several other inherited syndromes, including multiple endocrine neoplasia type 2, von Hippel-Lindau disease and neurofibromatosis type 1, raise the risk of pheochromocytoma. Excess weight, physical inactivity and smoking have been suggested as possible contributors, but their effect is not well understood. Most adrenal cancers cannot be prevented, and having a risk factor does not mean someone will develop the disease.
Many adrenal tumors are first seen by chance. They turn up in up to 1 in 10 people who have a CT (computed tomography) or MRI (magnetic resonance imaging) scan that includes the adrenal glands, and most are benign. The assessment that follows answers two questions: how likely is the tumor to be cancer, and is it making extra hormones? Imaging answers the first question. A CT scan shows a tumor's size, shape and density, measured in Hounsfield units (HU), a scale of how dense tissue looks on a scan taken without contrast dye. A uniform tumor measuring 10 HU or less is considered benign whatever its size and needs no further imaging. A tumor larger than 4 cm (about 1.5 inches) that looks uneven or measures above 20 HU carries enough risk of cancer that surgery is usually recommended. Tumors in between are reviewed by a team of specialists, sometimes with an MRI or a PET (positron emission tomography) scan. Blood and urine tests answer the second question, and they are done even when there are no symptoms, because hormone levels can be abnormal before symptoms appear. Everyone with an adrenal tumor should be tested for metanephrines (breakdown products of adrenaline that reveal a pheochromocytoma) and have a dexamethasone suppression test, which shows whether cortisol production switches off as it should. After the standard overnight 1 mg test, a blood cortisol above 1.8 micrograms per deciliter (50 nmol/L) means the tumor may be making cortisol on its own. Aldosterone, renin, potassium and sex hormones are checked when blood pressure, potassium or symptoms point that way. Unlike many cancers, an adrenal tumor that might be cancer is usually not sampled with a needle biopsy beforehand. A biopsy could spread cancer cells, and benign and cancerous adrenal tumors can look alike under the microscope. Instead the whole tumor is removed and examined by a pathologist, who also measures how quickly the cells are dividing. A biopsy may still be used on an area where the cancer appears to have spread, such as the liver.
Treatment depends on whether the tumor is cancer, which hormones it makes and how far it has spread. A small, benign-looking tumor that makes no extra hormones usually does not need surgery. A benign tumor that overproduces a hormone is often removed to correct the hormone excess, and medicines can control the hormone's effects in the meantime. For adrenocortical carcinoma, surgery to remove the affected adrenal gland (adrenalectomy) is the main treatment and, for cancer found at an early stage, can be curative. The aim is to remove the whole tumor in one piece, along with nearby lymph nodes and sometimes part of a neighboring organ such as the kidney or liver. Guidelines recommend that the operation be done by surgeons experienced in adrenal cancer surgery, and that treatment be planned by a specialist team familiar with this rare cancer. Because people have two adrenal glands, losing one generally does not cause lasting problems on its own. A pheochromocytoma needs medicines that block the effects of its hormones before surgery, which makes the operation safer. When the cancer is likely to return, for example when it could not be removed completely or its cells were dividing quickly (a Ki-67 score above 10%), doctors may suggest mitotane (Lysodren) after surgery. Mitotane is a pill that destroys adrenal cortex cells, and it is also the main medicine for adrenocortical carcinoma that cannot be removed. Loss of appetite, nausea, diarrhea and dizziness are common. Because it shuts down the body's own cortisol production, people taking it need steroid replacement and regular blood tests to check mitotane levels and hormones. It can harm a developing baby, so effective nonhormonal birth control is needed. For cancer that has spread or cannot be removed, treatment aims to slow the cancer, relieve symptoms and extend life. Options include mitotane alone or with chemotherapy (etoposide, doxorubicin and cisplatin), radiation or ablation to treat specific areas, surgery for selected areas of spread, and medicines that lower excess hormones. Clinical trials of immunotherapy and targeted drugs may also be an option.
The outlook depends heavily on what kind of tumor it is. A benign tumor that makes no extra hormones usually causes no harm. When a hormone-producing tumor is removed, the goal is to end the hormone excess and the problems it was causing, such as high blood pressure. Adrenocortical carcinoma is more serious, and outcomes depend mainly on its stage, whether all of it could be removed and how fast the cells are dividing. In US data for adults diagnosed between 2015 and 2021, about 68% of people whose cancer was confined to the adrenal gland were alive five years later (compared with people without cancer), against about 10% when it had spread to distant organs. These figures describe people treated years ago and cannot predict one person's course. The cancer can return even after successful surgery, so follow-up includes physical exams, scans and hormone blood tests for years. If it comes back, more surgery, radiation or medicines may help for a time. Daily life during and after treatment often involves managing hormones as well as the cancer. Adrenal surgery and mitotane can leave the body short of cortisol, a state called adrenal insufficiency that causes fatigue, weakness, weight loss and low blood pressure. It is treated with daily replacement pills, and people are usually taught to raise the dose when they are ill and to carry medical identification. Mitotane can also lower thyroid hormone and, in men, testosterone, which are checked and treated if needed. Because adrenocortical carcinoma at a young age can point to an inherited syndrome, testing for one may be recommended, and the results can matter for relatives too.
Ask for a full adrenal assessment if a scan finds an adrenal tumor by chance, if blood pressure is high and hard to control, or if you notice changes that suggest hormone excess, such as weight gain in the face and trunk with thin arms and legs, new facial hair, a deepening voice, missed periods, or episodes of headache, sweating and a pounding heart. A lump, fullness or pain in the abdomen or back that does not go away also deserves evaluation. If you take mitotane or cortisol replacement, contact your care team right away if you develop an infection, are injured, have another significant illness, or cannot take your steroid pills for any reason, because your dose may need to change. Symptoms of an adrenal crisis, such as severe weakness, confusion, fainting, persistent vomiting, severe abdominal or flank pain, or a high fever in someone whose cortisol may be low, are an emergency. Call 911 or go to an emergency room, and tell the staff about the adrenal condition and steroid treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Adrenal Gland Cancer is like, what's helped you, or ask the community a question.